BRIM BIOTECHNOLOGY
Founded in 2013, Quanfu Biotechnology Co., Ltd. (hereinafter referred to as Quanfu Biotech) is based in Taiwan and uses the core competitiveness of the translation science field to integrate the virtual team's operating model and is committed to the development of innovative drugs. โโThe professional team of Quanfu Biotech has screened the innovation sources of domestic and foreign companies with rich experience in new drug development, including: academic research, small biotechnology compa... nies, and international pharmaceutical companies, for joint research and development, technology introduction, etc. In a way that closely combines the energy of both parties to develop drug development, and then introduces the most suitable CRO and CMO strategic partners to promote innovative drugs to the โproof of conceptโ (POC) stage, followed by authorization and partnering. In this way, the research and development of innovative drugs will be handed over to the most potential development team, and the late clinical trials of drug research and development will be carried out to push the products to the market.
BRIM BIOTECHNOLOGY
Industry:
Biotechnology Pharmaceutical
Founded:
2013-01-01
Address:
Taipei, T'ai-pei, Taiwan
Country:
Taiwan
Website Url:
http://www.brimbiotech.com
Status:
Active
Contact:
+886-2-2659-8586
Email Addresses:
[email protected]
Total Funding:
18 M USD
Technology used in webpage:
SPF Google Apps For Business Google Maps Microsoft Azure DNS
Similar Organizations
Amyndas Pharmaceuticals S.A.
Amyndas is a pharmaceutical company
CloudKrate
CloudKrate is a biotechnology and pharmaceutical company.
Galaxy Biotech
Galaxy Biotech is a pharmaceutical company.
Swift Biotechnology
Swift Biotechnology is a Phermaceutical Company.
SynCore Biotechnology
SynCore Biotechnology is a biopharmaceutical company
Current Employees Featured
Founder
Official Site Inspections
http://www.brimbiotech.com Semrush global rank: 5.52 M Semrush visits lastest month: 1.54 K
- Host name: 103-123-243-29.static.ip.net.tw
- IP address: 103.123.243.29
- Location: Taiwan
- Latitude: 23.5
- Longitude: 121
- Timezone: Asia/Taipei
More informations about "BRIM Biotechnology" on Search Engine
BRIM Biotechnology - BRIM Biotechnology, Inc.
BRIM Biotechnology - BRIM Biotechnology, Inc. Bringing transformational treatments to patients sooner. Applying integrated and efficient translational science to develop new treatments that help combat and cure diseases. Our Pipeline.See details»
BRIM Biotechnology | About Us
BRIM Biotechnology applies integrated and efficient translational science to develop new treatments that help combat and cure disease. The company was founded in August 2013 in Taiwan by a team of seasoned, entrepreneurial global pharma experts.See details»
BRIM Biotechnology, Inc. | LinkedIn
About us. BRIM is a clinical-stage company developing novel peptide treatments for hard-to-treat diseases. BRIMโs first-in-class assets are based on its innovative stem cell regenerative PDSP...See details»
BRIM Biotechnology - Crunchbase Company Profile & Funding
About. BRIM Biotechnology is a pharmaceutical company. Taipei, T'ai-pei, Taiwan. 11-50. Series E. Private. www.brimbiotech.com/ 56,380. Highlights. Total Funding Amount. Unlock for free. Contacts 4. Employee Profiles 2. Similar Companies 45. Company Insights. Is BRIM Biotechnology experiencing growth? Powered by AI.See details»
Investors - BRIM Biotechnology, Inc.
BRIM Biotechnology (TPEx 6885) is a clinical-stage biotechnology company led by global pharma experts, using translational science to develop novel regenerative peptide treatments for hard-to-treat conditions in the areas of โฆSee details»
BRIM Biotechnology, Inc. and Ora, Inc. Announce New โฆ
May 23, 2022 BRIM Biotechnology, Inc. ("BRIM") a clinical-stage company developing novel regenerative therapies in ophthalmology, today announces it has entered into a new strategic partnership with Ora®,...See details»
BRIM Biotechnology, Inc. raises $20 million in Series E funding โฆ
Dec 2, 2022 BRIM Biotechnology, Inc. was established in July 2013 to accelerate the development and transformation of early research technology platforms to clinical drug candidates. BRIM applies efficient translational science to develop new treatments that help combat and cure disease.See details»
BRIM Biotechnology, Inc. and Ora, Inc. announce new โฆ
May 16, 2022 BRIM Biotechnology, Inc. is a clinical-stage company developing novel regenerative therapies in ophthalmology and degenerative joint diseases.See details»
BRIM Biotech raises $20 million in Series E funding round
Dec 1, 2022 12:13. BRIM Biotechnology, a clinical-stage biotechnology company advancing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, has raised $20 million in โฆSee details»
BRIM Biotechnology strengthens leadership team in preparation โฆ
BRIM Biotechnology strengthens leadership team in preparation for transformational year ahead. Board of Directors elects Andrew Lin as the new Chairman of the Board and appoints Dr Wen-Chyi Shyu as the new CEO.See details»
Corporate Governance - BRIM Biotechnology, Inc.
INVESTORS. Corporate Governance. Board of Directors. The Board consults with staff, advisers, regulators, and other stakeholders when identifying key resources and relationships on which the business relies. The Board is led by the Chairman and comprises nine members: six Directors and three Independent Directors.See details»
BRIM Biotechnology - Funding, Financials, Valuation & Investors
BRIM Biotechnology. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Funding Rounds 7. Total Funding Amount. Unlock โฆSee details»
BRIM Biotechnology, Inc. | VentureRadar
"BRIM Biotechnology is a preclinical / clinical stage company established in 2013 in Taipei, Taiwan. The company's core strengths reside in translational sciences and integrated operation management. Our mandate is to develop novel drug to meet unmet medical needs while keeping the development cost down.See details»
BRIM Biotechnology announces new leadership team
Feb 21, 2023 BRIM Biotechnology, Inc. (BRIM, TPEx 6885), a clinical-stage company developing novel regenerative therapies to help combat and cure ophthalmology and degenerative joint diseases, is pleased to announce that Andrew Lin was elected as the new Chairman of the Board on 8th February, 2023, and that the new board has appointed Dr. โฆSee details»
BRIM Biotechnology, Inc.: Drug pipelines, Patents, Clinical trials ...
Jan 24, 2024 BRIM Biotechnology, Inc.: Drug pipelines, Patents, Clinical trials - Synapse. Public Company |. 2013 |. Taiwan Province, China. |. 10-50. | ROCO: 6885 |. www.brimbiotech.com. Last update 24 Jan 2024. Overview. Pipeline. Deal. Profit. Grant & Funding (NIH) Investment. Financing. Overview. Tags. Eye Diseases. Nervous System โฆSee details»
BRIM Biotechnology - Recent News & Activity - Crunchbase
News โข Mar 29, 2024. www.tradingview.com โ Cash from operating activities of BRIM BIOTECHNOLOGY INC โ TPEX:6885 โ TradingView. News โข Dec 19, 2023. Yahoo Finance โ Dry Eye Disease Market to Register Immense Growth During ... News โข Sep 13, 2023. The Pharma Letter โ BRIM Biotech closes a $45.8 million rights issue. News โข Jun 26, โฆSee details»
BRIM Biotechnology | News | Drug Development
Taipei, Taiwan, 9th May, 2023, BRIM Biotechnology, Inc. (โBRIM,โ TPEx 6885), a clinical-stage biotechnology company focusing on developing regenerative peptides for ophthalmology and degenerative joint diseases, announced today that the Board of Directors has approved a seasoned equity offering thatโฆ 2023/04/18.See details»
BRIM BIOTECHNOLOGY, INC. - BIO International Convention | BIO
Explore the webinar opportunities for interactive, online learning about emerging issues in biotechnology public policy, scientific progress, and raising capital, plus methods to benefit from BIOโs membership services.See details»
BRIM Biotechnology - Contacts, Employees, Board Members
Organization. BRIM Biotechnology. Connect to CRM. Summary Financials People Technology Signals & News Similar Companies. Highlights. Employee Profiles 2. Contacts 4. About. BRIM Biotechnology has 2 current employee profiles, including Founder and CEO Haishan Jang. Contacts. CEO. 1 email found. View. Sales Manager. 1 email found. โฆSee details»
Corporate Sustainability - BRIM Biotechnology, Inc.
BRIM's vision is to bring sustainable & affordable healthcare innovation to the world. Learn more about our commitment to people & the planet.See details»